News

Press Release Issued:
IASIC Opposes the Removal of Cannabis from Schedule 1

BURLINGTON, Vermont – June 25, 2024 – The International Academy on the Science and Impact of Cannabis (IASIC) released its official statement against the proposed rescheduling of Cannabis from Schedule I to Schedule III of the Controlled Substances Act:

As physicians and concerned citizens of the United States of America, the International Academy on the Science and Impact of Cannabis believes that re-scheduling will have immediate and irreparable harm to the public health and vehemently oppose the removal of cannabis from Schedule 1. Specific objections include (1) The Department of Health and Human Services (HHS) inappropriately changed the definition of currently acceptable medical use (CAMU); (2) Even under the new definition, cannabis still does not meet the requirements for CAMU; (3) Proper regulation of cannabis as a schedule 3 drug cannot be achieved while non-medical cannabis commerce is allowed.

“HHS and those who are pushing rescheduling of cannabis are unaware or ignoring the huge amount of science on the medical harms of cannabis. There is zero benefit and only problems to be had from rescheduling,” said Eric A. Voth, MD, FACP, President and Chairman of the Board, The International Academy on the Science and Impact of Cannabis.

An official request for a hearing with the DEA has been submitted by IASIC during the current open comment period, with its leadership urging the presentation of medical and scientific research from its physician-driven organization of international experts on cannabis.

IASIC has provided substantial education and background on the impending harm of the proposed rescheduling in its monthly speaker series on June 11th as well as on the High Truths on Drugs and Addiction podcast with episode #182: High Truths on Drugs and Addiction on Rescheduling of Marijuana with IASIC.

Guest Editorial: The Association of Cannabis Potency with Adverse Psychiatric Effects of Cannabis

August 6, 2023 No Comments

By David A. Gorelick, MD, PhD, DLFAPA, FASAMDept. of Psychiatry, University of Maryland School of MedicineEditor-in-Chief, Journal of Cannabis Research Cannabis potency, the content of ∆9-tetrahydrocannabinol (THC), usually expressed as the percentage of dry weight, has increased substantially worldwide over the past four decades [1]. This higher potency poses a risk of increased harms because

Read More »

Association of Mandatory Warning Signs for Cannabis Use During Pregnancy With Cannabis Use Beliefs and Behaviors

July 6, 2023 No Comments

Question Are policies mandating warning signs regarding the harms of cannabis use during pregnancy associated with beliefs and behaviors? Findings This cross-sectional study used data from 2063 US-based survey respondents who were or had recently been pregnant and found that, among people who used cannabis during pregnancy, living in a state with a warning signs

Read More »

How Men’s Cannabis Use Could Affect Their Kids’ Health

November 4, 2022 No Comments

Decades of research have shown us how mothers’ consumption of marijuana during pregnancy can affect the health and development of their children. Fetal exposure to tetrahydrocannabinol (or THC, the active ingredient in marijuana) has been linked to lower birth weights and birth defects, higher aggression, and poorer attention in infants as well as impulse control,

Read More »

Self-reported marijuana use and cardiac arrhythmias (from the Multiethnic Study of Atherosclerosis)

October 28, 2022 No Comments

Marijuana use among all age groups has been increasing, including among older adults aged ≥65 years. There is a lack of epidemiologic data examining arrhythmia risk among users of marijuana. We evaluated cross-sectional associations between current and past marijuana smoking and arrhythmias among 1485 participants from the Multiethnic Study of Atherosclerosis who underwent extended ambulatory

Read More »

Stanford study links marijuana use to increased heart attack risk

October 26, 2022 No Comments

A robust new study led by researchers from Stanford University has found a strong association between increased risk of heart attack and regular marijuana use. The study indicates THC can trigger inflammation in blood vessel cells and the researchers call for medical marijuana users to be aware of potential cardiovascular risks. Published in the journal

Read More »

Bus driver ate pot gummies, passed out on I-95 in Stratford

October 21, 2022 No Comments

A Boston bus driver says he didn’t know the gummy candies he was snacking on while driving passengers home from a state casino were loaded with THC, the active ingredient in cannabis. But state police said that was no comfort to his 38 terrified passengers on their way home from a day at the Mohegan

Read More »

First Medical Textbook on Cannabis in Medicine

Listen to podcast High Truths on Drugs and Addiction on your favorite platform. ​Hightruth.com

Most Recent News

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Read More »

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Read More »

IASIC Speaker Series Presents: Case Report on Cannabis-Induced Acute Encephalopathy in Elderly After Taking CBD

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Read More »
Scroll to Top